¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Mumps Virus Vaccine Live SubQ"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vaccine rash
    ¹é½Å¹ßÁø
  • vaccine therapy
    ¹é½Å¿ä¹ý
  • attenuated virus
    ¾àµ¶È­¹ÙÀÌ·¯½º
  • avian neurolymphomatosis virus
    Á¶·ù½Å°æ¸²ÇÁÁ¾Áõ¹ÙÀÌ·¯½º
  • adeno-associated satellite virus
    ¾Æµ¥³ë°ü·ÃÀ§¼º¹ÙÀÌ·¯½º
  • adeno-associated virus
    ¾Æµ¥³ë°ü·Ã¹ÙÀÌ·¯½º
  • Bayou virus
    ¹ÙÀ¯¹ÙÀÌ·¯½º
  • croup-associated virus
    Å©·çÇÁ°ü·Ã¹ÙÀÌ·¯½º
  • defective virus
    °á¼Õ¹ÙÀÌ·¯½º
  • Duvenhage virus
    µàº¥ÇìÀÌÁî¹ÙÀÌ·¯½º
  • dengue virus
    µ­±â¹ÙÀÌ·¯½º
  • DNA virus
    DNA¹ÙÀÌ·¯½º
  • enteric cytopathogenic human orphan virus
    ¿¡ÄÚ¹ÙÀÌ·¯½º
  • enveloped virus
    ²®Áúº¸À¯¹ÙÀÌ·¯½º, ¿ÜÇǺ¸À¯¹ÙÀÌ·¯½º
  • epidemic gastroenteritis virus
    À¯ÇàÀ§Àå¿°¹ÙÀÌ·¯½º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • human papilloma virus
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º
  • influenza virus
    ÀÎÇ÷翣ÀÚ¹ÙÀÌ·¯½º
  • neurotropic virus
    ½Å°æÄ£È­¹ÙÀÌ·¯½º, Çâ½Å°æ¹ÙÀÌ·¯½º
  • passenger virus
    Àϰú¼º¹ÙÀÌ·¯½º, ³ª±×³×¹ÙÀÌ·¯½º
  • respiratory syncytial virus
    È£Èí±â¼¼Æ÷À¶ÇÕ¹ÙÀÌ·¯½º
  • RNA virus
    ¾Ë¿£¿¡À̹ÙÀÌ·¯½º
  • simian virus
    ¿ø¼þÀ̹ÙÀÌ·¯½º
  • Varicella-zoster virus
    ¼öµÎ´ë»óÆ÷Áø¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • vaccine therapy
    ¹é½Å¿ä¹ý
  • vaccine
    ¹é½Å
  • aberrant virus
    ºñÀüÇü¹ÙÀÌ·¯½º
  • adeno-associated virus
    ¾Æµ¥³ë¹ÙÀÌ·¯½ºÀÇÁ¸¹ÙÀÌ·¯½º
  • adeno-satellite virus
    ¾Æµ¥³ë¹ÙÀÌ·¯½ºÀ§¼º¹ÙÀÌ·¯½º
  • adventitious virus
    ¿ì¹ß¹ÙÀÌ·¯½º
  • attenuated virus
    ¾àµ¶È­¹ÙÀÌ·¯½º
  • avipox virus
    Á¶·ùÆø½º¹ÙÀÌ·¯½º
  • cell-associated virus
    ¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
  • challenge virus
    °ø°Ý¿ë¹ÙÀÌ·¯½º, Á¢Á¾¹ÙÀÌ·¯½º
  • croup-associated virus
    Å©·ì°ü·Ã¹ÙÀÌ·¯½º
  • dermatotropic virus
    ÇǺÎģȭ¹ÙÀÌ·¯½º
  • DNA virus
    µð¿£¿¡À̹ÙÀÌ·¯½º
  • enteric cytopathogenic human orphan virus
    ¿¡ÄÚ¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antismallpox vaccine
    ¸¶¸¶¹é½Å.
  • glycerinated vaccine
    ±Û¸®¼¼¸°Ã³¸®¿ÎÁø.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • pertussis vaccine
    ¹éÀÏÇØ¹é½Å.
  • polyvalent vaccine
    ´Ù°¡¿ÎÁø.
  • polyvalent vaccine
    ´Ù°¡¹é½Å
  • polyvalent vaccine
    ´Ù°¡¿ÎÁø.
  • rabies vaccine
    ±¤°ßº´¹é½Å.
  • rabies vaccine
    ±¤°ßº´¹é½Å.
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å.
  • Aedes iridescent virus
    ½£¸ð±â ¹«Áö°³ ¹ÙÀÌ·¯½º
  • African horse sickness virus
    ¾ÆÇÁ¸®Ä« ¸»º´¹ÙÀÌ·¯½º
  • African swine fever virus
    ¾ÆÇÁ¸®Ä« µÅÁö¿­¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • metastatic mumps
    ÀüÀ̼º ¸ØÇÁ½º.
  • metastatic mumps
    ÀüÀ̼º ¸ØÇÁ½º.
  • mumps
    º¼°Å¸®, ¸ØÇÁ½º, À¯Ç༺ ÀÌÇϼ±¿°(êüú¼àõì¼ù»àÍæú).
  • mumps
    À¯Ç༺ ÀÌÇϼ±¿°(×µú¼àõ ì¼ù»àÍæú)
  • mumps
    º¼°Å¸®
  • mumps
    ¸Ø½º, À¯Ç༺ÀÌÇϼ±¿°, º¼°Å¸®
  • mumps
    À¯Ç༺ÀÌÇϼ±¿°, º¼°Å¸®
  • mumps orchitis
    ÀÌÇϼ±¿°¼º °íȯ¿°(ì¼ù»àÍæúàõÍÂü¯æú).
  • mumps orchitis
    ÀÌÇϼ±¿°¼º °íȯ¿°(¡­àõ ÍÂü¯æú)
  • parotitis,mumps
    ¸ØÇÁ½º, º¼°Å¸®, À¯Ç༺ ÀÌÇϼ±¿°(×µú¼àõ ì¼ù»àÍæú)
  • variola major virus ; smallpox virus
    (´ë)¸¶¸¶¹ÙÀÌ·¯½º.
  • variola major virus ; smallpox virus
    (´ë)¸¶¸¶¹ÙÀÌ·¯½º.
  • variola minor virus ³ª alastrim virus
    ¼Ò¸¶¸¶¹ÙÀÌ·¯½º.
  • variola minor virus ³ª alastrim virus
    ¼Ò¸¶¸¶¹ÙÀÌ·¯½º.
  • anthrax vaccine
    źÀú¹é½Å.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cancer-inducing virus
    ¹ß¾Ï(Û¡äß) ¹ÙÀÌ·¯½º
  • C-type virus
    "C-Çü(û¡) ¹ÙÀÌ·¯½º, (ÔÒ) C-type particles"
  • C virus
    C ¹ÙÀÌ·¯½º
  • defective virus
    °á¼Õ(ÌÀáß) ¹ÙÀÌ·¯½º
  • deficient virus
    °áÇÌ(ÌÀù¹) ¹ÙÀÌ·¯½º
  • DNA-RNA virus
    "DNA-RNA ¹ÙÀÌ·¯½º, (ÔÒ) retrovirus"
  • DNA virus
    DNA ¹ÙÀÌ·¯½º (ÔÒ) a DNA-containing virus
  • endogenous virus
    ³»Àç(Ò®î¤) ¹ÙÀÌ·¯½º
  • helper virus
    µµ¿òÀÌ ¹ÙÀÌ·¯½º
  • heterocapsidic virus
    ÀÌÁ¾(ì¶ðú)
  • indicator virus
    Áö½Ã(ò¦ãÆ) ¹ÙÀÌ·¯½º
  • lysogenic virus
    ¿ë¿ø¼º(éÁê«àõ)¹ÙÀÌ·¯½º
  • lytic virus
    ¿ëÇØ(éÁú°)¹ÙÀÌ·¯½º
  • masked virus
    ÀºÆó(ëßøÌ) ¹ÙÀÌ·¯½º
  • oncogenic virus
    ¹ß¾Ï(Û¡äß) ¹ÙÀÌ·¯½º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RV random variable; rat virus; Rauscher virus; rectovaginal; reinforcement value; renal vein; residual ...
MMR   1) Measles, Mumps, Rubella; È«¿ª, ¸ØÇÁ½º, dzÁø
  2) Mass Miniature Radiography...
MUMPS Massachusetts General Hospital Utility Multi-Programming System
HEV health and environment; hemagglutinating encephalomyelitis virus; hepatitis E virus; hepato-encephal...
SFV Semliki Forest virus; shipping fever virus; Shope fibroma virus; squirrel fibroma virus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MMR MEASLES: mumps-rubella
MMR Measles, mumps and rubella
LW live weight
BPV Bordatella pertussis vaccine
DTP Diphtheria-tetanus-pertussis vaccine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • rubella vaccine
    dzÁø ¹é½Å
  • sabin's vaccine
    ¼¼À̺ó ¹é½Å
    °æ±¸ »ýÆú¸®¿À ¹ÙÀÌ·¯½º.
  • Salk's vaccine
    ¼ÒÅ© ¹é½Å
    ºÎȰȭ Æú¸® ¹é½Å, Æú¸®¿À ¹ÙÀÌ·¯½º¸¦ Æ÷¸£¸»¸°À¸·Î ó¸®ÇÑ °Í.
  • univalent vaccine
    Àϰ¡ ¹é½Å
  • vaccine exanthem
    Á¾µÎÁø
  • vaccine rash
    ¹é½Å ¹ßÁø
  • adeno-associated virus
    ¾Æµ¥³ë °ü·Ã ¹ÙÀÌ·¯½º
  • adventitious virus
    ¿ì¹ß¼º ¹ÙÀÌ·¯½º
  • animal virus
    µ¿¹° ¹ÙÀÌ·¯½º
  • attenuated virus
    µ¶¼º ¾àÈ­ ¹ÙÀÌ·¯½º, º¯¼º ¾àµ¶ ¹ÙÀÌ·¯½º
    ¿¬¼ÓÀû µ¿¹°°è´ë ¶Ç´Â ±âŸ ¹æ¹ý¿¡ ÀÇÇØ º´¿ø¼ºÀ» °¨¼Ò½ÃŲ ¹ÙÀÌ·¯½º.
  • avian infectious bronchitis virus
    Á¶·ù °¨¿°¼º ±â°üÁö¿° ¹ÙÀÌ·¯½º
  • avian influenza virus
    Á¶·ù ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º
  • avian leukosis complex virus
    Á¶·ù ¹éÇ÷±¸Áõ ¹ÙÀÌ·¯½º
  • avian myeloblastosis virus
    Á¶·ù °ñ¼ö¾Æ¼¼Æ÷Áõ ¹ÙÀÌ·¯½º
  • bacterial virus
    ¼¼±Õ ¹ÙÀÌ·¯½º, ¹ÚÅ׸®¿ÀÆÄÁö
    ¼¼±Õ¼º ¹ÙÀÌ·¯½º.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
mumps An infectious acute viral disease affecting the parotid glands. The gonads, meninges and pancreas can also be affected. The causative agent is a paramyxovirus. Humans are the only natural host for this disease.
Common symptoms include weakness, fever, sore throat, malaise and puffiness to the cheeks (due to parotid gland swelling). Patients are contagious 1 day prior to the onset of swelling until the swelling is gone. Recovery is generally in 2 weeks.
(27 Sep 1997)
mumps immunization The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination.
(12 Dec 1998)
mumps in pregnancy It has been stated, we believe erroneously, that mumps is dangerous when contracted during pregnancy. For example, vetter (infect med 14:730-733, 1997), citing a single 1980 article, writes: mumps infection during the first trimester of pregnancy can increase the rate of spontaneous abortion. Congenital anomalies associated with mumps infection during pregnancy include endocardial fibroelastosis; imperforate anus; spina bifida; and auditory, optic, and urogenital deformities. However, shepard in his authorative catalog of teratogenic agents (j hopkins u press, 8th edition, 1995) does not consider that mumps merits inclusion as a proven or even possible teratogenic agent, that is as an agent capable of causing a spontaneous abortion (a miscarriage) or causing congenital malformations (the baby is born with birth defects). Furthermore, mumps does not even warrant mention in smith's recognizable patterns of human malformation (by kl jones, wb saunders co., 5th edition, 1997), a key standard text on dysmorphology (the study of malformations). Based also on our review of the facts available at this time (oct, 1997), we conclude that there is insufficient evidence to label mumps as a particular hazard in pregnancy.
(12 Dec 1998)
mumps meningoencephalitis A usually benign nervous system infection arising during the active phase of clinical mumps parotiditis.
(05 Mar 2000)
mumps orchitis <pathology> A mumps infection that has affected the testicles. Approximately 20-35% of postpubertal males with mumps will develop this complication.
(27 Sep 1997)
mumps sensitivity test A skin test for sensitivity to mumps, in which inactivated mumps virus is used as antigen.
(05 Mar 2000)
mumps skin test antigen A sterile suspension of killed mumps virus in isotonic sodium chloride solution, used to determine susceptibility to mumps or to confirm previous exposure.
(05 Mar 2000)
immunization, mumps See Immunization, MMR.
(12 Dec 1998)
bovine virus diarrhoea virus A virus of the genus Pestivirus, in the family Togaviridae, causing bovine virus diarrhoea; New York, Oregon, and Indiana strains of the virus are recognised.
Synonym: mucosal disease virus.
(05 Mar 2000)
acellular vaccine <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells.
(13 Nov 1997)
adjuvant vaccine A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate).
(05 Mar 2000)
aqueous vaccine A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion.
(05 Mar 2000)
attenuated vaccine Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine.
(05 Mar 2000)
autogenous vaccine A vaccine made from a culture of the patient's own bacteria.
(05 Mar 2000)
bacillus Calmette-Guerin vaccine <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection.
(15 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Friend virus
    ÇÁ·»µå ¹ÙÀÌ·¯½º
  • filamentous virus
    ¼¶»ç»ó ¹ÙÀÌ·¯½º
  • filterable virus
    ¿©°ú¼º ¹ÙÀÌ·¯½º(º´¿øÃ¼)
  • parainfluenza virus
    ÆÄ¶óÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º(»ç¶÷,¸¶¼Ò,µÅÁö µî¿¡ È£Èí ÁúȯÀ» ÀÏÀ¸Å´)
  • polyoma virus
    Æú¸®¿À¸¶ ¹ÙÀÌ·¯½º
  • virus
    ¹ÙÀÌ·¯½º;¿©°ú¼º º´¿øÃ¼;(Á¤½Å,µµ´ö»óÀÇ)ÇØµ¶
  • virus warfare
    ¼¼±ÕÀü
  • virus x
    ÀÎÇ÷翣ÀÚ ºñ½ÁÇÑ Áõ»óÀ» ÀÏÀ¸Å°´Â Á¤Ã¼ºÒ¸íÀÇ ¹ÙÀÌ·¯½º º´µ¶
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á